Atlas Trials

Safety of REPEVAX® Given One Month After REVAXIS®

Clinical trial NCT00400309 · COMPLETED

Trial details

NCT number
NCT00400309
Sponsor
Sanofi Pasteur, a Sanofi Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Healthy Adult
Start date
2006-06-01
Primary completion
2007-02-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.